InvestorsHub Logo
Followers 79
Posts 24524
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 08/02/2017 8:06:04 AM

Wednesday, August 02, 2017 8:06:04 AM

Post# of 27431
CLSN - 1.69 Pre-market now at 1.79/1.84

Celsion Announces Latest Translational Data from the OVATION Study in Newly Diagnosed Advanced Ovarian Cancer Patients



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.